V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20031054 | 20013251 | null | 109 | Adjuvant (A) | 2014-10-13 | 2014-10-27 | FEC + DOCETAXEL | N | N | 20109287 | FEC + DOCETAXEL |
| 20031055 | 20013252 | 1.61 | 57.8 | Adjuvant (A) | 2017-06-27 | 2017-07-04 | FEC + DOCETAXEL | 02 | Y | 20109295 | FEC + DOCETAXEL |
| 20031056 | 20013252 | 1.66 | 70.2 | Neo-adjuvant (N) | 2015-08-16 | 2015-08-26 | FEC 100 + DOCETAXEL | N | N | 20109295 | FEC + DOCETAXEL |
| 20031057 | 20013253 | 1.59 | null | Neo-adjuvant (N) | 2015-07-30 | 2015-08-17 | FEC + DOCETAXEL | N | N | 20109298 | FEC + DOCETAXEL |
| 20031058 | 20073056 | 1.59 | 69.8 | Not known (9) | 2013-10-11 | 2013-10-24 | FEC + DOCETAXEL | 2 | null | 20109300 | FEC + DOCETAXEL |
| 20031059 | 20013254 | 1.53 | 105.5 | Adjuvant (A) | 2016-09-26 | 2016-10-30 | FEC + DOCETAXEL | N | N | 20109301 | FEC + DOCETAXEL |
| 20031060 | 20013254 | 1.75 | 62.6 | Not known (9) | 2017-11-04 | 2017-11-27 | FEC + DOCETAXEL | 2 | N | 20109301 | FEC + DOCETAXEL |
| 20031061 | 20013255 | null | null | null | 2017-04-27 | 2017-05-01 | FEC 100 + DOCETAXEL | N | N | 20109308 | FEC + DOCETAXEL |
| 20031062 | 20013255 | 1.59 | 93 | Neo-adjuvant (N) | 2016-01-05 | 2016-02-03 | FEC + DOCETAXEL | N | null | 20109308 | FEC + DOCETAXEL |
| 20031063 | 20013256 | 1.74 | 60 | Adjuvant (A) | 2016-09-03 | 2016-09-15 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20109322 | FEC + DOCETAXEL |
| 20031064 | 20013256 | 1.66 | 66.5 | Adjuvant (A) | null | 2015-06-04 | FEC + DOCETAXEL | N | N | 20109322 | FEC + DOCETAXEL |
| 20031065 | 20013257 | 1.69 | 68 | Adjuvant (A) | 2015-08-02 | 2015-08-08 | FEC + DOCETAXEL | 2 | N | 20109331 | FEC + DOCETAXEL |
| 20031066 | 20013258 | 1.69 | 58.8 | Not known (9) | 2017-04-20 | 2017-05-12 | FEC + DOCETAXEL | N | N | 20109333 | FEC + DOCETAXEL |
| 20031067 | 20013258 | 1.59 | 73.1 | Curative (C) | 2015-07-16 | 2015-07-16 | FEC + DOCETAXEL | 02 | N | 20109333 | FEC + DOCETAXEL |
| 20031068 | 20013258 | 1.48 | 62.2 | Adjuvant (A) | 2017-12-26 | 2018-01-11 | FEC + DOCETAXEL | 2 | N | 20109333 | FEC + DOCETAXEL |
| 20031069 | 20128173 | 1.6 | 64.4 | Adjuvant (A) | 2017-11-07 | 2017-11-27 | FEC + DOCETAXEL | 02 | N | 20109344 | FEC + DOCETAXEL |
| 20031070 | 20013259 | 1.71 | 77 | Neo-adjuvant (N) | null | 2014-02-17 | FEC 100 + DOCETAXEL | null | null | 20109346 | FEC + DOCETAXEL |
| 20031071 | 20013259 | 1.66 | 64.4 | Adjuvant (A) | null | 2016-05-19 | FEC 100 + DOCETAXEL | null | N | 20109346 | FEC + DOCETAXEL |
| 20031072 | 20013260 | 1.68 | 58 | Adjuvant (A) | 2013-10-01 | 2013-10-17 | FEC + DOCETAXEL | N | N | 20109350 | FEC + DOCETAXEL |
| 20031073 | 20013260 | 1.66 | 70 | Neo-adjuvant (N) | 2013-12-18 | 2013-12-25 | FEC + DOCETAXEL | 02 | N | 20109350 | FEC + DOCETAXEL |
| 20031074 | 20013261 | 1.62 | null | Adjuvant (A) | 2017-02-12 | 2017-03-12 | FEC + DOCETAXEL | null | null | 20109362 | FEC + DOCETAXEL |
| 20031075 | 20013261 | 1.56 | 69.6 | Adjuvant (A) | 2017-01-07 | 2017-01-23 | FEC 100 + DOCETAXEL | 2 | N | 20109362 | FEC + DOCETAXEL |
| 20031076 | 20013262 | null | 71 | Adjuvant (A) | 2016-03-23 | 2016-03-23 | FEC + DOCETAXEL | 2 | N | 20109364 | FEC + DOCETAXEL |
| 20031077 | 20013262 | 1.59 | null | Neo-adjuvant (N) | 2017-11-29 | 2017-12-20 | FEC 100 + DOCETAXEL | N | N | 20109364 | FEC + DOCETAXEL |
| 20031078 | 20013263 | 1.8 | 48.6 | Adjuvant (A) | 2017-06-04 | 2017-06-08 | FEC + DOCETAXEL | 2 | N | 20109367 | FEC + DOCETAXEL |
| 20031079 | 20013263 | 1.73 | 132 | Adjuvant (A) | 2018-01-01 | 2018-01-13 | FEC + DOCETAXEL | 02 | Y | 20109367 | FEC + DOCETAXEL |
| 20031080 | 20013264 | 1.7 | 75.4 | Neo-adjuvant (N) | 2015-06-19 | 2015-06-23 | FEC 100 + DOCETAXEL | N | N | 20109374 | FEC + DOCETAXEL |
| 20031081 | 20013265 | 1.66 | 92.6 | Curative (C) | null | 2016-06-20 | FEC + DOCETAXEL | N | N | 20109375 | FEC + DOCETAXEL |
| 20031082 | 20013265 | 1.53 | 62 | Adjuvant (A) | 2014-05-19 | 2014-05-28 | FEC + DOCETAXEL | 02 | Y | 20109375 | FEC + DOCETAXEL |
| 20031083 | 20013266 | 1.73 | 72.5 | Adjuvant (A) | 2017-04-30 | 2017-05-25 | FEC + DOCETAXEL | 99 | null | 20109386 | FEC + DOCETAXEL |
| 20031084 | 20013266 | 1.63 | 59 | Adjuvant (A) | 2016-01-08 | 2016-01-28 | FEC + DOCETAXEL | 2 | N | 20109386 | FEC + DOCETAXEL |
| 20031085 | 20013266 | 1.61 | 74 | Adjuvant (A) | 2016-03-25 | 2016-04-08 | FEC + DOCETAXEL | N | N | 20109386 | FEC + DOCETAXEL |
| 20031086 | 20013267 | 1.7 | 67 | Adjuvant (A) | 2015-07-29 | 2015-07-30 | FEC + DOCETAXEL | N | N | 20109404 | FEC + DOCETAXEL |
| 20031087 | 20013268 | null | null | Adjuvant (A) | 2014-09-19 | 2014-10-20 | FEC + DOCETAXEL | 2 | N | 20109410 | FEC + DOCETAXEL |
| 20031088 | 20013268 | 1.57 | 74.7 | Neo-adjuvant (N) | 2016-05-04 | 2016-05-15 | FEC + DOCETAXEL | 02 | N | 20109410 | FEC + DOCETAXEL |
| 20031089 | 20013268 | 1.64 | 71 | null | 2015-06-19 | 2015-07-04 | FEC 100 + DOCETAXEL | N | N | 20109410 | FEC + DOCETAXEL |
| 20031090 | 20013268 | null | 83 | Adjuvant (A) | 2017-01-21 | 2017-02-25 | FEC 100 + DOCETAXEL | N | N | 20109410 | FEC + DOCETAXEL |
| 20031092 | 20013269 | 1.73 | 78.7 | Adjuvant (A) | 2016-08-23 | 2016-09-07 | FEC + DOCETAXEL | N | N | 20109422 | FEC + DOCETAXEL |
| 20031093 | 20013270 | null | 58 | Curative (C) | 2015-10-24 | 2015-10-31 | FEC + DOCETAXEL | 02 | N | 20109426 | FEC + DOCETAXEL |
| 20031094 | 20013270 | 1.69 | 79.9 | Adjuvant (A) | 2016-09-01 | 2016-09-08 | FEC + DOCETAXEL | 02 | N | 20109426 | FEC + DOCETAXEL |
| 20031095 | 20013270 | 1.54 | null | Adjuvant (A) | 2016-12-14 | 2017-01-04 | FEC + DOCETAXEL | N | N | 20109426 | FEC + DOCETAXEL |
| 20031096 | 20013270 | 1.68 | 51.499 | Adjuvant (A) | 2017-11-13 | 2017-11-20 | FEC + DOCETAXEL | N | N | 20109426 | FEC + DOCETAXEL |
| 20031097 | 20013271 | 1.69 | 85.5 | Adjuvant (A) | 2014-09-08 | 2014-09-08 | FEC + DOCETAXEL | 02 | null | 20109450 | FEC + DOCETAXEL |
| 20031098 | 20013271 | 1.63 | 60.4 | Adjuvant (A) | 2015-09-21 | 2015-10-13 | FEC 100 + DOCETAXEL | N | N | 20109450 | FEC + DOCETAXEL |
| 20031099 | 20013271 | null | null | Neo-adjuvant (N) | 2013-04-20 | 2013-05-19 | FEC + DOCETAXEL | N | N | 20109450 | FEC + DOCETAXEL |
| 20031100 | 20013271 | 1.67 | 64 | Adjuvant (A) | 2016-02-15 | 2016-02-18 | FEC + DOCETAXEL | 02 | null | 20109450 | FEC + DOCETAXEL |
| 20031101 | 20013272 | 1.62 | null | Adjuvant (A) | 2013-06-12 | 2013-06-14 | FEC 100 + DOCETAXEL | Y | null | 20109454 | FEC + DOCETAXEL |
| 20031102 | 20013273 | 1.6 | 57 | Adjuvant (A) | null | 2016-06-16 | FEC 100 + DOCETAXEL | null | N | 20109462 | FEC + DOCETAXEL |
| 20031103 | 20013273 | 1.62 | 66.3 | Disease modification (D) | 2014-12-16 | 2014-12-23 | FEC 100 + DOCETAXEL | 02 | N | 20109462 | FEC + DOCETAXEL |
| 20031104 | 20013273 | 1.77 | 106.3 | Adjuvant (A) | 2015-10-29 | 2015-11-19 | FEC + DOCETAXEL | N | null | 20109462 | FEC + DOCETAXEL |